# EDGAR Filing Document

**Accession Number:** 0000314489
**File Stem:** 0001776678-25-000012
**Filing Date:** 2025-12
**Character Count:** 13574
**Document Hash:** 570f9661d511a647fbdd35d66679ecca
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001776678-25-000012.hdr.sgml**: 20251205

**ACCESSION NUMBER**: 0001776678-25-000012

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20251203

**FILED AS OF DATE**: 20251205

**DATE AS OF CHANGE**: 20251205

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Maddox Mike
- **CENTRAL INDEX KEY:** 0001776678

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-42677
- **FILM NUMBER:** 251552074

**MAIL ADDRESS:**
- **STREET 1:** 11440 TOMAHAWK CREEK PARKWAY
- **CITY:** LEAWOOD
- **STATE:** KS
- **ZIP:** 66211
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** FIRST BUSEY CORP /NV/
- **CENTRAL INDEX KEY:** 0000314489
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 371078406
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 11440 TOMAHAWK CREEK PKWY
- **CITY:** LEAWOOD
- **STATE:** KS
- **ZIP:** 66211
- **BUSINESS PHONE:** 2173654544

**MAIL ADDRESS:**
- **STREET 1:** 11440 TOMAHAWK CREEK PKWY
- **CITY:** LEAWOOD
- **STATE:** KS
- **ZIP:** 66211

## Ex-24

**EXHIBIT 24**

**FIRST BUSEY CORPORATION**

**POWER OF ATTORNEY<br>(SECTIONS 13(d) AND 16(a) MATTERS)**

KNOW ALL BY THESE PRESENTS, THAT the undersigned, MICHAEL J. MADDOX, hereby makes, constitutes, and appoints each of Lynette Strode, Catherine Alqallaf, and Carolyn Slattery, of First Busey Corporation (the "Company"), acting jointly and individually, as the undersigned's true and lawful attorneys-in-fact, with full power and authority, including full power of substitution, as hereinafter described on behalf of and in the undersigned's name, place and stead to:

&nbsp;&nbsp;&nbsp;&nbsp;1.seek, obtain or maintain filing codes and passwords enabling the undersigned to make electronic filings with the United States Securities and Exchange Commission of reports required by Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules promulgated thereunder (the "Exchange Act"), including completing, executing and submitting any Form ID (Uniform Application for Access Codes to File on EDGAR) or other application for Edgar access, and any other related agreement, certificate or document;

&nbsp;&nbsp;&nbsp;&nbsp;2.execute for and on behalf of the undersigned, in the undersigned's capacity as a more than five percent (5%) stockholder (if applicable) of the Company, any Schedule 13D or Schedule 13G and any amendments thereto in accordance with Section 13(d) of the Securities Exchange Act of 1934 (the "Exchange Act") and the rules thereunder;

&nbsp;&nbsp;&nbsp;&nbsp;3.execute for and on behalf of the undersigned, in the undersigned's capacity as a director, officer or stockholder of the Company or a subsidiary of the Company, Forms 3, 4 and 5 in accordance with Section 16(a) of the Exchange Act and the rules thereunder or any amendments thereto;

&nbsp;&nbsp;&nbsp;&nbsp;4.execute for and on behalf of the undersigned, in the undersigned's capacity as an affiliate of the Company, any Form 144;

&nbsp;&nbsp;&nbsp;&nbsp;5.do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 144, 3, 4 or 5 and any such Schedule 13D or Schedule 13G and any amendments thereto and timely file such form or schedule with the United States Securities and Exchange Commission, the Nasdaq Stock Market, the Company and any stock exchange or similar authority;

&nbsp;&nbsp;&nbsp;&nbsp;6.seek or obtain, as the undersigned's representative and on the undersigned's behalf, information on transactions in the Company's securities from any third party, including brokers, employee benefit plan administrators and trustees, and the undersigned hereby authorizes any such person to release any such information to the undersigned and approves and ratifies any such release of information; and

&nbsp;&nbsp;&nbsp;&nbsp;7.take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact's discretion.

------

**EXHIBIT 24**

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power or substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with Section 13(d) or Section 16 of the Exchange Act.

This Power of Attorney shall remain in full force and effect until (i) the undersigned is no longer required to file Forms 144, 3, 4 and 5 and Schedule 13D or Schedule 13G (including any amendments thereto) with respect to the undersigned's holdings of and transactions in securities issued by the Company, (ii) the aforenamed attorneys-in-fact are no longer employed by the Company or its subsidiaries in which case this Power of Attorney shall automatically terminate (but previous actions shall remain valid) with respect to such attorney-in-fact immediately upon his or her termination of employment, or (iii) this Power of Attorney is earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

*For good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the undersigned, to the fullest extent permitted by law: (i) agrees to hold the attorneys-in-fact and the Company harmless from all liability, loss, cost, damage or expense of any nature, including reasonable attorneys' fees and expenses sustained or incurred by the attorneys-in-fact or Company in connection with the performance, or non-performance, of the actions described in paragraphs (1) - (7) above; and (ii) irrevocably releases and waives any and all claims (in law or equity) against the attorneys-in-fact and the Company, and all of their respective heirs, estates, successors and assigns, as the case may be, relating to the performance, or non-performance, of the actions described in paragraphs (1) - (7) above.*

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of the 26th day of September, 2025.

---

| | |
|:---|:---|
| /s/ MICHAEL J. MADDOX | /s/ MICHAEL J. MADDOX |
| Print Name: | Michael J. Maddox |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Maddox Mike<br><sub>(Last) (First) (Middle)</sub><br>11440 TOMAHAWK CREEK PARKWAY<br><sub>(Street)</sub><br>LEAWOOD, KS 66211<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-12-03 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_President_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>FIRST BUSEY CORP /NV/ [ BUSE ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 211582.2937 | D |  |
| Series A Non-Cumulative Perpetual Preferred Stock |  |  |  |  |  |  |  | 50 | D |  |
| Common Stock |  |  |  |  |  |  |  | 4739<sup>(1)</sup> | I | Spouse |
| Series A Non-Cumulative Perpetual Preferred Stock |  |  |  |  |  |  |  | 100<sup>(1)</sup> | I | Spouse |
| Depositary Shares, 1/40 interest in Series B Preferred Stock<sup>(2)</sup> | 2025-12-03 |  | P |  | 1000 | A | 25.519<sup>(3)</sup> | 40280<sup>(1)</sup> | I | Spouse |
| Depositary Shares, 1/40 interest in Series B Preferred Stock<sup>(2)</sup> |  |  |  |  |  |  |  | 460<sup>(1)</sup> | I | Stepson |
| Depositary Shares, 1/40 interest in Series B Preferred Stock<sup>(2)</sup> |  |  |  |  |  |  |  | 460<sup>(1)</sup> | I | Stepson |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Stock Appreciation Right | $9.37 |  |  |  |  |  |  | 2025-03-01 | 2028-01-24 | Common Stock | 38142 |  | 38142 | D |  |
| Stock Appreciation Right | $11.24 |  |  |  |  |  |  | 2025-03-01 | 2028-05-01 | Common Stock | 15257 |  | 15257 | D |  |
| Stock Appreciation Right | $14.01 |  |  |  |  |  |  | 2025-03-01 | 2030-06-01 | Common Stock | 17292 |  | 17292 | D |  |
| Stock Appreciation Right | $21.35 |  |  |  |  |  |  | 2025-03-01 | 2033-07-26 | Common Stock | 40050 |  | 40050 | D |  |

---

### Footnotes:

(1) The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.

(2) Each Depositary Share represents a 1/40th interest in a share of the issuer's 8.25% Fixed Rate Non-Cumulative Perpetual Preferred Stock, Series B, par value $0.001 per share.

(3) The price reported above reflects the weighted average purchase price.  The purchase was executed in multiple trades at prices ranging from $25.51 to $25.52 inclusive.  The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the shares purchased at each separate price within the range set forth in this footnote (3) to this Form 4.

**Signature:** /s/ Carolyn Slattery, attorney-in-fact  
**Date:** 2025-12-05

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**